# GCP Laboratories – FDA Inspection, May 13, 2022

Source: https://www.keypedia.com/records/fda_inspections/gcp-laboratories/8c396915-6675-4587-a3d3-b85d9ac715b8
Source feed: FDA_Inspections

> FDA inspection 1169512 of GCP Laboratories, May 13, 2022. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR part 211. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169512
- Company Name: GCP Laboratories
- Inspection Date: 2022-05-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 7

## Related Documents

- FDA Inspection 1099910 - 2019-08-07
- FDA Inspection 1039235 - 2018-01-10
- FDA Inspection 913182 - 2015-02-04
- FDA Inspection 752460 - 2011-11-04
- [FDA Inspection 634442 - 2009-12-09](https://www.keypedia.com/records/fda_inspections/gcp-laboratories/3e4cae67-49ef-4467-bb9a-35576ade2883)

Company: https://www.keypedia.com/companies/gcp-laboratories/4db6975e-4a27-4b14-b43c-6e61b5bc7db9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c